Prot #M11-327: A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Project: Research project

Project Details

StatusFinished
Effective start/end date4/23/13 → 4/23/19

Funding

  • AbbVie Inc. (Prot #M11-327)